Post-Transplant Lymphoproliferative Disorder Presenting as CD20-Negative Plasmablastic Lymphoma in the Lung | Zendy

Tasneem Kaleem | Zendy; Jennifer A. Crozier | Zendy; David M. Menke | Zendy; Taimur Sher | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Post-Transplant Lymphoproliferative Disorder Presenting as CD20-Negative Plasmablastic Lymphoma in the Lung

Author(s) -

Tasneem Kaleem,

Jennifer A. Crozier,

David M. Menke,

Taimur Sher

Publication year - 2016

Publication title -

rare tumors

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.285

H-Index - 15

eISSN - 2036-3613

pISSN - 2036-3605

DOI - 10.4081/rt.2016.6220

Subject(s) - plasmablastic lymphoma , medicine , lymphoma , lymphoproliferative disorders , presentation (obstetrics) , epstein–barr virus , post transplant lymphoproliferative disorder , complication , lung , lung transplantation , epstein–barr virus infection , cd20 , transplantation , human immunodeficiency virus (hiv) , pathology , dermatology , virus , immunology , rituximab , surgery

Post-transplant lymphoproliferative disorders (PTLD) are a serious complication of transplantation with a high mortality. Most PTLD present within the first year of transplantation and are associated with Epstein-Barr virus (EBV) infection. Plasmablastic lymphoma (PBL) is a rare but aggressive disease originally described in patients with HIV, presenting most commonly in the jaw and oral mucosa. To our knowledge, this is the first case of PBL presenting as PTLD of the lung in a HIV and EBV negative patient. Given the increasing number of transplants performed, we would like to share this uncommon presentation of PTLD as PBL

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research